Fort Detrick Biological Laboratory has never felt so powerless.
The elites in the laboratory exhausted all their strength and spent a lot of time to conquer a technology. They finally felt confident that they had achieved good results, but they were not worth mentioning in front of Changtian Technology.
Sometimes, this is not only a sense of powerlessness, but also a serious sense of frustration.
This incident has a great impact on the American elite, especially the elite in the scientific research community.
For the first time, everyone corrected their mentality and looked up to Changtian Technology, and had to admit that the technical foundation of Changtian Technology has far exceeded the recognition of American academic circles.
Will we continue to conquer Changtian Technology’s biomedical technology?
This is the problem facing the Fort Detrick Biological Laboratory.
The financial backers behind it have completely cut off funding, and the U.S. military is also trying its best to disassociate itself from the experiment.
There is no point in continuing to complete this experiment.
Moreover, reporters all over the world are now staring at me, and the pressure from public opinion and morality is extremely high.
The experiments on joint falling have only been temporarily suspended.
The Fort Detrick Biological Laboratory and the relevant health departments in the United States, as well as the related foundations behind it, have been experiencing a lot of headaches during this time.
Recently, public opinion has labeled them crimes against humanity.
During this period, relevant resources are working hard to reduce the deaths of patients who have received intensive care centers in the United States.
In just a few days, the relevant news that made a lot of noise some time ago suddenly disappeared from the public opinion circle.
The attitude of relevant departments and capital in the United States is that you believe it or not, but as long as I don’t admit it, it’s untrue.
But this time, the biological laboratory and the capital behind it have completely offended a large part of the American elite.
Thanks to the efforts of Waldson and others, it was actually after brutal capital struggles one after another.
It seems that he is trying to clear himself of suspicion, and it also seems that he is under great pressure in the elite world.
The two major medical regulatory agencies, the National Institutes of Health (NIH) and the Food and Drug Administration (FDA), were helpless and finally opened a crack at Changtian Technology's critical care center.
NIH and FDA announced that for the health of domestic patients, they have agreed to cooperate with Changtian Technology's critical care center in the United States and with medical institutions in the United States to jointly build critical care centers in the United States.
The number of critical care centers approved for the first time is two.
The designated partners in the United States include companies such as Johnson & Johnson, Pfizer, and Mosadrode, as well as medical institutions such as the Mayo Clinic.
After hearing the news, local patients in the United States cheered, thinking that this was the victory of justice over evil and the greatest victory.
Of course the patients are happy because they no longer have to travel to Mexico or Canada for treatment.
There is no need to worry about your own treatment, worrying that the treatment you receive overseas does not comply with the laws of the United States, and you will encounter some restrictions or unfair treatment when you return to the country.
In addition to patients in the United States, the happiest companies include Johnson & Johnson, Pfizer and other companies.
In the past few years, they have cooperated with Changtian Technology to build a large number of overseas critical care centers and made a lot of profits from them.
Taking Pfizer as an example, profits from intensive care centers currently account for more than 40% of total annual profits.
This kind of profit is very terrible.
If the China Securities Treatment Center can be built in the United States, it will definitely reduce the cost of treatment for patients and attract more patients to the critical treatment center for treatment.
This means profit.
Means crazy profits.
The United States is a typical capitalist country, and it is a typical anarchist and capitalist country.
All anarchy is caused by America's long history of immigration.
What capital pursues in this country is not the prosperity of the country or the unity of the people, but the maximum profit.
In order to pursue such profits, they can kill each other, or they can make their enemies and themselves become friends instantly.
The most typical example is the United States after World War II.
During World War II, the Pacific War in the East caused many deaths in the United States.
Pearl Harbor, in particular, left an indelible shadow on generations of Americans.
However, after World War II, the United States quickly formed an alliance with Japan, provided a large amount of technology transfer and financial support to Japan, and quickly turned Japan into a developed country.
American capital has also made huge profits from it.
After the 1970s, Japan's economy took off rapidly, and the development of semiconductor and other industries even squeezed the domestic industries of the United States.
The capital of the United States has ruthlessly harvested the leeks of the East.
Such repetition is not determined by emotional factors, but by interests.
So the attitude towards Changtian Technology is the same.
There are no deep-seated hatreds or sincere feelings, only interests.
Capital that can gain benefits from Changtian Technology is willing to cooperate with Changtian Technology, and does not care whether the technology developed by Changtian Technology or the capital achievements achieved will allow Xia to replace the United States and become the most powerful country in the world.
They only hope to cooperate with Changtian Technology to achieve greater benefits, and companies such as Pfizer are among them.
The capital that has been deprived of its interests by Changtian Technology will of course hate Changtian Technology deeply, and it is natural that the interest disputes between capitals will be elevated to morality or the state.
And this time, the capital that was willing to cooperate with Changtian Technology gained the upper hand in terms of morality and strength, so the critical care center suddenly opened up the American market.
In order to enter the US market, Changtian Technology actually applied to relevant US departments and provided some technical information.
However, all these efforts were rejected by the relevant departments in the United States.
But now, Changtian Technology has not opened its mouth at all, and the United States has taken the initiative to release the market.
This can fully demonstrate that the U.S. government is also serving capital rather than serving the people.
Pfizer and other companies immediately contacted Changtian Technology, hoping to obtain a cooperation agreement with Changtian Technology and build a critical care center in the United States as soon as possible to introduce relevant equipment, drugs and talents.
In order to gain an advantage in the competition, Pfizer even offered extremely favorable conditions, changing the previous 50-50 stratification of both parties to 46-46, of which Changtian Technology accounted for 60%, and Changtian Technology even occupied 70% in previous years.
The profit can be negotiated.
Because Pfizer knows very well that critical care centers are definitely a monopoly industry in the US market.
Now as long as you firmly control the market in your own hands, it doesn't matter if you make less profit, after all, there is still a long time to come.
Relevant media revealed the news that the United States had opened up the market to Changtian Technology's critical treatment center, and that Pfizer and other companies urgently sent representatives to Changtian Technology to negotiate with Wang Xiang.
As soon as the news came out, many netizens around the world began to complain.
"It's just a joke. Some time ago, the media in the United States said that combined colony therapy is not safe at all and can easily lead to patient death. Now the market for Changtian Technology's critical treatment center is open and they are allowed to set up hospitals in the United States to carry out treatment activities.
It doesn’t even need to pass clinical trials in the United States.”
"The NIH and FDA in the United States actually approved Changtian Technology's critical care center at the same time. Is this a Changtian Technology critical care center? It is very safe!"
"That's right, Changtian Technology, which has been approved by NIH and FDA, has entered the American market, which is equivalent to a disguised recognition of the clinical trial results of Xia Guo. Some time ago, the media also said that the joint action therapy in the critical care center is unsafe. Americans will not
Are they allowed to enter the market?"
“I scolded the New York Times for being lonely, and now I’m really slapping myself in the face.”
After Xia Guo's netizens heard the news, they felt very excited.
Because this is the first time in the history of Xia State, the first time that a medical institution of Xia State has been actively invited by the United States to enter the American market without applying.
The technology in the United States is indeed very advanced, and the technology is also very top-notch.
The most representative ones are the semiconductor industry and the biomedical industry.
The elite in the United States have full confidence in the biomedical industry and believe that their medicine is number one in the world.
With this kind of confidence, the United States has its own set of biomedical standards. It is very difficult for foreign medical institutions, including those from developed European countries, to enter the American market.
A few years ago, it would have been absolutely unimaginable that a Xia medical institution would enter the American market, treat American people, and make money from American people.
But Changtian Technology did it.
"Changtian Technology's critical care center can enter the US market openly. This time it has given a loud slap to the American medical community and a loud slap to the Nobel Prize Organizing Committee. The critical care center has allowed the US to
Relevant departments and biomedical executives are fully and clearly aware that Xia Guo has surpassed the current highest level in the United States in biomedicine."
This is what a big V from Xia State wrote on Weibo.
After this Weibo post was posted, it quickly became a hot search topic that day and received millions of likes and more than 100,000 comments.
"What the blogger said is very reasonable. Our top scientific research in Xia is not inferior to that of the United States, so there is no need to belittle ourselves."
"This time the relevant national biological laboratory in the United States did something so disgusting that they took off the bottom of their pants and had no choice but to introduce the critical treatment center of Changtian Technology. The purpose is to calm the domestic elite.
dissatisfied."
In the international market, with the fermentation of this news, consumers are even more concerned about Changtian Technology's products.
The Hanhai 2 mobile phone, which fell into slow sales some time ago, continues to maintain extremely strong sales growth.
Toyo, on the other hand, continues to send representatives to negotiate with Changtian Technology, hoping to introduce bio-power plants.
European countries suffering from energy problems, including Germany, Switzerland and Belgium, are seriously considering whether to learn from France and introduce Changtian Technology's microbial power station.
Under the unanimous optimism of external capital, Yuedong Internet and Bird shares recovered their losses in the previous period, and their stock prices fell compared with them. They rose by 30% on the last trading day.
The sense of smell of capital is the most sensitive.
They have used real money to tell consumers that they believe there is absolutely no problem with Changtian Technology's products.
Changzezhou Changtian Technology Headquarters.
Chen Xiao also learned about the news that the United States has allowed intensive care centers to enter the market, and that Pfizer and other companies have sent representatives to negotiate with Changzhou Zhu and Santian Technology.
Wang Xiang, who was reporting this incident, felt a little helpless.
"At the beginning, we tried every means to pry open the US market, but were blocked. In the end, we chose Mexico and Canada, which are relatively close to the mainland of the United States."
"So, do we really have to thank the Fort Detrick Biological Laboratory?"
Chen Xiao also laughed.
"In fact, as long as you understand that American Wall Street capital is not united, the matter will be very easy to solve."
Wang Xiang nodded and said: "Are we going to continue to cooperate with Pfizer and other companies this time? Are we sure we want to enter the US market?"
Chen Xiao thought for a while and then said: "We must cooperate, and our products must enter the American market. In what specific ways we will cooperate, how the shares between the two parties will be divided, how the profits will be divided, I will leave this matter to you and Qu
Ping went to talk."
"But we have to grasp one principle, that is, technology and management rights must be in our hands."
“Changtian Technology’s products have never officially entered the U.S. market from beginning to end.”
"This market seems open, but in fact it is closed and very unfriendly to third world countries."
"I hope to use the critical care center as a breakthrough to completely open the door to the U.S. market so that our biological products, mobile phones, and electronic products can enter."
After confirming the cooperation plan, Wang Xiang and Qu Ping immediately negotiated with Pfizer and other companies.
In the end, both parties happily reached a cooperation agreement.
Changtian Technology has established three critical care treatment centers in the United States with Pfizer and Merck respectively.
These three critical care centers are located in Washington, New York and California.
All fixed asset investments in building critical care centers in the United States were made by Pfizer and other companies, and Changtian Technology did not have to spend a penny.
In addition, Changtian Technology will dispatch technical personnel to assist in the construction of three critical care centers.
The salaries and subsidies of technical personnel are borne by Changtian Technology, but the corresponding amounts are paid to Changtian Technology by Pfizer and other companies.
The purpose of this is to prevent technicians from being short-handed and short-handed.
After the construction of the critical care center is completed, the personnel and financial rights will be in the hands of Changtian Technology.
The profits of both parties are divided according to 4:6, of which Changtian Technology holds 60%. This period will last for 5 years.
After 5 years, the two parties will divide it 50-50.
And whether it is personnel, finance or other matters, Common Technology has a veto power.